SCHEMBL536763

SCHEMBL536763

O=[C]CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10937782 0.97
SCHEMBL563582 0.81
SCHEMBL2442929 0.79
SCHEMBL1401237 0.77 TSHR (0.63)
SCHEMBL3980051 0.77 TSHR (0.63)
SCHEMBL7382880 0.77 TSHR (0.63)
SCHEMBL3972155 0.77 TSHR (0.63)
SCHEMBL970516 0.77 TSHR (0.63)
SCHEMBL1654498 0.77 TSHR (0.63)
SCHEMBL374773 0.77 TSHR (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230102146-A1 MULTI-TARGET TYROSINE KINASE INHIBITOR SHENZHEN NEPTUNUS PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. (CN) 2023-03-30 US claimed
EP-4108666-A1 MULTI-TARGET TYROSINE KINASE INHIBITOR Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd. (CN) 2022-12-28 EP claimed
CN-113336768-B Multi-target tyrosine kinase inhibitor 深圳海王医药科技研究院有限公司 2022-08-19 CN claimed
EP-3110452-B1 BIOACTIVE AGENTS INCLUDED IN FUNCTIONALIZED STARCH HAVING A SINGLE HELIX V-STRUCTURE B ORGANIC FILMS CORP (CA) 2021-12-15 EP claimed
CN-113336768-A Multi-target tyrosine kinase inhibitor 深圳海王医药科技研究院有限公司 2021-09-03 CN claimed
CN-107580596-B Sulfimidoylpurine ketone compounds and derivatives for the treatment and prevention of viral infections 豪夫迈·罗氏有限公司 2020-07-14 CN claimed
US-20200109144-A1 Sulfonimidoylpurinone Compounds HOFFMANN-LA ROCHE INC. (US) 2020-04-09 US claimed
CN-108003136-B Aminomethyl phenyl yl pyridines class compound and its application in DPP-4 enzyme inhibitor 上海医药工业研究院 2019-09-13 CN claimed
US-20190031618-A1 BENZIMIDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS JANSSEN PHARMACEUTICA NV (BE) 2019-01-31 US claimed
US-10118900-B2 Benzimidazole derivatives useful as CB-1 inverse agonists JANSSEN PHARMACEUTICA NV (BE) 2018-11-06 US claimed
EP-0230347-A1 Macrolide compounds, their preparation and use Sankyo Company Limited (JP) 1987-07-29 EP claimed
US-4659734-A BACTERICIDES, FUNGICIDES NIPPON SHINYAKU CO., LTD. (JP) 1987-04-21 US claimed
US-4619943-A NEUROLEPTIC AGENTS RAO KOPPAKA V 1986-10-28 US claimed
EP-0121265-A2 Method of heterogeneous reaction NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1984-10-10 EP claimed
US-4419522-A ANTITUMOR AGENTS CHINOIN GYOGYSZER VEGYESZETI TERMEKEK GYARA RT. (HU) 1983-12-06 US claimed
EP-0040435-B1 PEPTIDE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Eisai Co., Ltd. (JP) 1983-07-20 EP claimed
US-4317827-A 4-[4(or 3)-Acylaminophenyl]pyridines and their use as cardiotonics STERLING DRUG INC. (US) 1982-03-02 US claimed
EP-0040435-A1 Peptide derivatives and process for the preparation thereof Eisai Co., Ltd. (JP) 1981-11-25 EP claimed
US-3951964-A Method for preparing azines PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1976-04-20 US claimed
US-3943132-A Process for the preparation of hydrazones PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1976-03-09 US claimed